IPO News

Nephro Care India Limited plans to raise Rs. 35-40 crore from its upcoming IPO

Posted On : 2024-05-24 18:32:37( TIMEZONE : IST )

Nephro Care India Limited plans to raise Rs. 35-40 crore from its upcoming IPO

Nephro Care India Limited, a leading multi-speciality healthcare provider in East India, is planning to raise ₹35-40 crore through an initial public offering (IPO), subject to NSE Emerge approval. This strategic move will allow NCIL to expand its operations across India.

The company plans to use the net proceeds from the IPO to establish a multi-speciality hospital named 'Vivacity Multi Speciality Hospital' in Madhyamgram, Kolkata, West Bengal. The remaining capital will be used for general corporate purposes. The new hospital, a unit of Nephro Care India Limited, will reportedly include 100 inpatient beds, including a 30-bed critical care unit with ICU, HDU, RTU, and NICU facilities. Vivacity will offer treatment services in various disciplines, including cardiology, medical oncology, gastroenterology, gynecology, and an advanced renal transplant unit, making it the most advanced facility of its kind in East India.

Key Highlights of the IPO

Fresh Issuance: The IPO will consist of a fresh issuance of 45.84 lakh equity shares with a face value of ₹10 each.

Book Running Lead Manager: Corporate Capital Ventures Private Limited is the Book Running Lead Manager, and Bigshare Services Private Limited is the Registrar to the offer. Corporate Capital Ventures Private Limited has a history of successful SME IPOs, including Trust Fintech, Creative Graphics, Alpex Solar, Esconet Technologies, Rockingdeals, Accent Microcell, Oriana Power, Droneacharya, and Crayons Advertising.

Financial Performance: NCIL's financial performance is on the rise. The company posted a revenue of Rs. 19.90 crore and a profit (PAT) of Rs. 3.4 crore in the first nine months of FY 2023-24, compared to a revenue of Rs. 17.09 crore and a profit (PAT) of Rs. 1.94 crore in FY 2022-23.

Founded in Kolkata in 2014 by Dr. Pratim Sengupta, a leading nephrologist in India, Nephro Care aims to provide comprehensive medical services for kidney patients. Dr. Sengupta, with over 20 years of experience, has performed more than 1,000 kidney transplants and is a pioneer in holistic renal care that combines clinical intervention, yoga, and lifestyle support. He was awarded the "Bharat Jyoti Award" in 2019 for his outstanding achievements in the field.

Source : Equity Bulls


NephroCareIndia FundRaising IPO NSESME Emerge Approval